Brera Holdings PLC Class B Ordinary Shares (BREA) had the highest return between October 1, 2022 and February 29, 2024 by a US stock with a market cap of <= $7B, returning 2,159,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Brera Holdings PLC Class B Ordinary Shares (BREA) | 10/1/2022 - 2/29/2024 | 2,159,900% |
Azitra (AZTR) | 10/1/2022 - 2/29/2024 | 910,614.29% |
Foremost Lithium Resource & Technology Ltd Common stock (FMST) | 10/1/2022 - 2/29/2024 | 89,614.29% |
SS Innovations International Inc Common Stock (SSII) | 10/1/2022 - 2/29/2024 | 15,240.91% |
Cabaletta Bio (CABA) | 10/1/2022 - 2/29/2024 | 3,366.67% |
Castellum (CTM) | 10/1/2022 - 2/29/2024 | 2,791.09% |
Viking Therapeutics (VKTX) | 10/1/2022 - 2/29/2024 | 2,691.67% |
Soleno Therapeutics (SLNO) | 10/1/2022 - 2/29/2024 | 2,661.14% |
American Coastal Insurance (ACIC) | 10/1/2022 - 2/29/2024 | 1,989.71% |
Diversified Energy (DEC) | 10/1/2022 - 2/29/2024 | 1,862.52% |
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 10/1/2022 - 2/29/2024 | 1,470% |
COSCIENS Biopharma (CSCI) | 10/1/2022 - 2/29/2024 | 1,370.65% |
Direct Digital (DRCT) | 10/1/2022 - 2/29/2024 | 850.43% |
Powell Industries (POWL) | 10/1/2022 - 2/29/2024 | 788.23% |
Abercrombie & Fitch (ANF) | 10/1/2022 - 2/29/2024 | 701.51% |
Ardelyx (ARDX) | 10/1/2022 - 2/29/2024 | 676.67% |
Applied Therapeutics (APLT) | 10/1/2022 - 2/29/2024 | 665.59% |
Biohaven Pharmaceutical (BHVN) | 10/1/2022 - 2/29/2024 | 653.36% |
CSP (CSPI) | 10/1/2022 - 2/29/2024 | 573.68% |
Gaotu Techedu Inc DRC (GOTU) | 10/1/2022 - 2/29/2024 | 557.14% |
Immunovant (IMVT) | 10/1/2022 - 2/29/2024 | 523.81% |
Limbach (LMB) | 10/1/2022 - 2/29/2024 | 517.82% |
MoonLake Immunotherapeutics (MLTX) | 10/1/2022 - 2/29/2024 | 503% |
Applied Opt (AAOI) | 10/1/2022 - 2/29/2024 | 478.99% |
Corbus Pharmaceuticals (CRBP) | 10/1/2022 - 2/29/2024 | 477.03% |
